Previous studies based on the comprehensive analysis of genomics, epigenomics, transcriptomics, and clinical information of pancreatic cancer have demonstrated a significant negative correlation between A2ML1 gene expression level and methylation status. This evidence concerns the gene A2ML1 and familial pancreatic carcinoma.